Why Intervention Insights?

Cancer patients who suffer one or more relapses typically have already received a wide range of recommended therapies. Unfortunately, when multi-agent treatment regimens fail to stop the cancer, physicians are left with limited options for additional treatment.

Aggressive and recurring cancers are difficult to treat. Some cancers have high response rates to defined treatments, but others continue to progress, degrading the patient’s quality of life.

Science continues to make advances in both the ability to analyze the cancer genome and to understand how the disease may be treated. These results provide “genomic evidence,” providing valuable insight into the molecular basis of the cancer.

Published guidelines offer standard and accepted therapeutic options for specific classes of disease (such as breast cancer). Genomic evidence focuses on the tumor's molecular characteristics.

This approach is known as personalized medicine, and it compares a patient’s molecular cancer characteristics with the ever-growing collections of molecular knowledge to attempt to find personalized treatment paths.

Intervention Insights believes that a personal approach to cancer care can increase survival time, improve a patient’s quality of life, and offer treatments that increase the chances of response.

Guiding Principles

Mission

Improve the lives of patients afflicted with cancer through evidence-based therapeutic interventions that are applied by their community physicians

Goals

• Provide physicians with rational therapeutic strategies based on a patient’s unique molecular and clinical information
• Analyze data and return strategies and evidence to physicians in a timely and cost-effective manner
• Continuously improve our bioinformatics tools and analytical capabilities

Strategy

Leveraging the latest in bioinformatics tools and disease insights to organize expanding drug, disease, and molecular knowledge to serve our clinical partners

Our Belief System

We work toward achieving our mission, goals, and strategy by:

• Believing each person deserves our support in their fight to cure their cancer.
• Providing our physicians with relevant information describing the unique pharmacogenomic profile underlying each patient’s cancer
• Acknowledging that although many will lose their battle, we can at the very least help improve the quality of a patient’s life
• Applying the latest possible therapeutic information targeting a patient’s disease is not only logical but essential to the battle
• Acknowledging we can always do better and are committed to continuously improving our strategy, service, and support
• Believing if we do not act now and do the best we can ...we all lose